{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:18:08Z","timestamp":1791001088177,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The incidence of acute complications and mortality associated with COVID-19 remains poorly characterized. The aims of this systematic review and meta-analysis were to summarize the evidence on clinically relevant outcomes in hospitalized patients with COVID-19.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>MEDLINE, EMBASE, PubMed, and medRxiv were searched up to April 20, 2020, for studies including hospitalized symptomatic adult patients with laboratory-confirmed COVID-19. The primary outcomes were all-cause mortality and acute respiratory distress syndrome (ARDS). The secondary outcomes included acute cardiac or kidney injury, shock, coagulopathy, and venous thromboembolism. The main analysis was based on data from peer-reviewed studies. Summary estimates and the corresponding 95% prediction intervals (PIs) were obtained through meta-analyses.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 44 peer-reviewed studies with 14,866 COVID-19 patients were included. In general, risk of bias was high. All-cause mortality was 10% overall (95% PI, 2 to 39%; 1687\/14203 patients; 43 studies), 34% in patients admitted to intensive care units (95% PI, 8 to 76%; 659\/2368 patients; 10 studies), 83% in patients requiring invasive ventilation (95% PI, 1 to 100%; 180\/220 patients; 6 studies), and 75% in patients who developed ARDS (95% PI, 35 to 94%; 339\/455 patients; 11 studies). On average, ARDS occurred in 14% of patients (95% PI, 2 to 59%; 999\/6322 patients; 23 studies), acute cardiac injury in 15% (95% PI, 5 to 38%; 452\/2389 patients; 10 studies), venous thromboembolism in 15% (95% PI, 0 to 100%; patients; 3 studies), acute kidney injury in 6% (95% PI, 1 to 41%; 318\/4682 patients; 15 studies), coagulopathy in 6% (95% PI, 1 to 39%; 223\/3370 patients; 9 studies), and shock in 3% (95% PI, 0 to 61%; 203\/4309 patients; 13 studies).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Mortality was very high in critically ill patients based on very low-quality evidence due to striking heterogeneity and risk of bias. The incidence of clinically relevant outcomes was substantial, although reported by only one third of the studies suggesting considerable underreporting.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>PROSPERO registration ID for this study is CRD42020177243 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=177243\">https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=177243<\/jats:ext-link>).<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13054-020-03022-1","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T08:31:03Z","timestamp":1593678663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Nicola","family":"Potere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9729-3214","authenticated-orcid":false,"given":"Emanuele","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Candeloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Spoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W. S.","family":"Rutjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"10223","key":"3022_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet."},{"key":"3022_CR2","doi-asserted-by":"crossref","unstructured":"Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. The Journal of Heart and Lung Transplantation. 2020;39(5):405-407.","DOI":"10.1016\/j.healun.2020.03.012"},{"issue":"10229","key":"3022_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet."},{"key":"3022_CR4","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020.","DOI":"10.1001\/jama.2020.2648"},{"key":"3022_CR5","doi-asserted-by":"crossref","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.","DOI":"10.1016\/j.tmaid.2020.101623"},{"key":"3022_CR6","doi-asserted-by":"crossref","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020.","DOI":"10.1001\/jama.2020.4683"},{"key":"3022_CR7","doi-asserted-by":"crossref","unstructured":"Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis. 2020;S1473-3099(20)30244-9.","DOI":"10.1016\/S1473-3099(20)30244-9"},{"issue":"7","key":"3022_CR8","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med."},{"key":"3022_CR9","doi-asserted-by":"crossref","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance. Accessed: March 2020. WHO REFERENCE NUMBER: WHO\/2019-nCoV\/clinical\/2020.4 2020.","DOI":"10.15557\/PiMR.2020.0003"},{"issue":"7","key":"3022_CR10","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"key":"3022_CR11","unstructured":"National Health Commission of the People\u2019s Republic of China. The notice of launching guideline on diagnosis and treatment of the novel coronavirus pneumonia (5th edition). (Accessed 24 Mar 2020, at http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/3b09b894ac9b4204a79db5b8912d4440.shtml)."},{"issue":"9","key":"3022_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712\u20136.","journal-title":"ANZ J Surg"},{"key":"3022_CR13","unstructured":"Higgins J, Altman D, Sterne J. Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions version 5202017."},{"issue":"23","key":"3022_CR14","first-page":"2526","volume":"307","author":"ADT Force","year":"2012","unstructured":"Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526\u201333.","journal-title":"JAMA."},{"issue":"3","key":"3022_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486\u2013552.","journal-title":"Crit Care Med"},{"key":"3022_CR16","doi-asserted-by":"crossref","unstructured":"Summary of Recommendation Statements. Kidney Int Suppl (2011). 2012;2(1):8\u201312.","DOI":"10.1038\/kisup.2012.7"},{"issue":"3","key":"3022_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237\u201369.","journal-title":"Eur Heart J"},{"key":"3022_CR18","doi-asserted-by":"crossref","unstructured":"Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013.","DOI":"10.1111\/jth.12155"},{"key":"3022_CR19","doi-asserted-by":"crossref","unstructured":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020.","DOI":"10.1111\/jth.14810"},{"issue":"4","key":"3022_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the Scientific Standardization Committee of the International Society on Thrombosis Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692\u20134.","journal-title":"J Thromb Haemost"},{"key":"3022_CR21","doi-asserted-by":"crossref","unstructured":"Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020.","DOI":"10.1016\/S1473-3099(20)30243-7"},{"key":"3022_CR22","unstructured":"R Core Team (2019). R: a language and environment for statistical computing. R Foundation for statistical computing, Vienna, Austria. URL https:\/\/www.R-project.org\/2019)."},{"key":"3022_CR23","doi-asserted-by":"crossref","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787-1799.","DOI":"10.1056\/NEJMc2008043"},{"key":"3022_CR24","doi-asserted-by":"crossref","unstructured":"Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, et al. Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;ciaa243.","DOI":"10.1093\/cid\/ciaa243"},{"key":"3022_CR25","doi-asserted-by":"crossref","unstructured":"Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. Clinical progression of patients with COVID-19 in Shanghai. China. J Infect. 2020;80(5):e1-e6.","DOI":"10.1016\/j.jinf.2020.03.004"},{"key":"3022_CR26","doi-asserted-by":"crossref","unstructured":"Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020;glaa089.","DOI":"10.1093\/gerona\/glaa089"},{"key":"3022_CR27","doi-asserted-by":"crossref","unstructured":"Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020.","DOI":"10.1111\/jth.14830"},{"key":"3022_CR28","doi-asserted-by":"crossref","unstructured":"Fan Z, Chen L, Li J, Cheng X, Jingmao Y, Tian C, et al. Clinical features of COVID-19-related liver damage. Clin Gastroenterol Hepatol. 2020;18(7):1561-1566.","DOI":"10.1101\/2020.02.26.20026971"},{"key":"3022_CR29","doi-asserted-by":"crossref","unstructured":"Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with different severity: a multi-center study of clinical features. Am J Respir Crit Care Med. 2020;201(11):1380-1388.","DOI":"10.1164\/rccm.202002-0445OC"},{"issue":"1","key":"3022_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12931-020-01352-w","volume":"21","author":"L Gao","year":"2020","unstructured":"Gao L, Jiang D, Wen XS, Cheng XC, Sun M, He B, et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020;21(1):83.","journal-title":"Respir Res"},{"key":"3022_CR31","doi-asserted-by":"crossref","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-1581.","DOI":"10.1001\/jama.2020.4031"},{"key":"3022_CR32","unstructured":"Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;NEJMoa2007016."},{"key":"3022_CR33","doi-asserted-by":"crossref","unstructured":"Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.","DOI":"10.1183\/13993003.01227-2020"},{"key":"3022_CR34","doi-asserted-by":"crossref","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.","DOI":"10.1056\/NEJMoa2002032"},{"key":"3022_CR35","doi-asserted-by":"crossref","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;e201017.","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"3022_CR36","doi-asserted-by":"crossref","unstructured":"Han H, Xie L, Liu R, Yang J, Liu F, Wu K, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020;10.1002\/jmv.25809.","DOI":"10.1002\/jmv.25809"},{"key":"3022_CR37","doi-asserted-by":"crossref","unstructured":"Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002-1009.","DOI":"10.1136\/gutjnl-2020-320926"},{"key":"3022_CR38","doi-asserted-by":"crossref","unstructured":"Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;S0049-3848(20)30120-1.","DOI":"10.1016\/j.thromres.2020.04.013"},{"key":"3022_CR39","doi-asserted-by":"publisher","first-page":"104363","DOI":"10.1016\/j.jcv.2020.104363","volume":"127","author":"R Li","year":"2020","unstructured":"Li R, Tian J, Yang F, Lv L, Yu J, Sun G, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary hospital near Wuhan, China. J Clin Virol. 2020;127:104363.","journal-title":"J Clin Virol"},{"key":"3022_CR40","unstructured":"Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;S0091-6749(20)30495-4."},{"key":"3022_CR41","doi-asserted-by":"crossref","unstructured":"Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, et al. Analysis of epidemiological and clinical features in older patients with corona virus disease 2019 (COVID-19) out of Wuhan. Clin Infect Dis. 2020;ciaa242.","DOI":"10.1093\/cid\/ciaa242"},{"key":"3022_CR42","doi-asserted-by":"crossref","unstructured":"Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Inf Secur. 2020; 80(6):e14-e18.","DOI":"10.1016\/j.jinf.2020.03.005"},{"key":"3022_CR43","doi-asserted-by":"crossref","unstructured":"Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. 2020;133(9):1025-1031.","DOI":"10.1097\/CM9.0000000000000744"},{"issue":"9","key":"3022_CR44","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/CM9.0000000000000775","volume":"133","author":"W Liu","year":"2020","unstructured":"Liu W, Tao ZW, Lei W, Ming-Li Y, Kui L, Ling Z, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020;133(9):1032\u20131038.","journal-title":"Chin Med J"},{"key":"3022_CR45","doi-asserted-by":"crossref","unstructured":"Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. QJM. 2020;hcaa089.","DOI":"10.1093\/qjmed\/hcaa089"},{"issue":"4","key":"3022_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425\u201334.","journal-title":"Lancet Infect Dis"},{"key":"3022_CR47","doi-asserted-by":"crossref","unstructured":"Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;e200950.","DOI":"10.1001\/jamacardio.2020.0950"},{"issue":"5","key":"3022_CR48","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094\u20139.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3022_CR49","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844\u20137.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3022_CR50","first-page":"401","volume":"80","author":"S Tian","year":"2020","unstructured":"Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Inf Secur. 2020;80(4):401\u20136.","journal-title":"J Inf Secur"},{"key":"3022_CR51","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061-1069.","DOI":"10.1001\/jama.2020.1585"},{"key":"3022_CR52","doi-asserted-by":"crossref","unstructured":"Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Inf Secur. 2020; 80(6):639-645.","DOI":"10.1016\/j.jinf.2020.03.019"},{"key":"3022_CR53","doi-asserted-by":"crossref","unstructured":"Wang L, Li X, Chen H, Yan S, Li D, Li Y, et al. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol. 2020:51(5):343-348.","DOI":"10.1159\/000507471"},{"key":"3022_CR54","doi-asserted-by":"crossref","unstructured":"Wang Y, Lu X, Chen H, Chen T, Su N, Huang F, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020; 201(11):1430-1434.","DOI":"10.1164\/rccm.202003-0736LE"},{"key":"3022_CR55","doi-asserted-by":"crossref","unstructured":"Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;200843.","DOI":"10.1148\/radiol.2020200843"},{"key":"3022_CR56","doi-asserted-by":"crossref","unstructured":"Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;ciaa272.","DOI":"10.1093\/cid\/ciaa272"},{"key":"3022_CR57","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;e200994.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"3022_CR58","doi-asserted-by":"crossref","unstructured":"Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis. 2020;ciaa199.","DOI":"10.1093\/cid\/ciaa199"},{"key":"3022_CR59","doi-asserted-by":"publisher","first-page":"m606","DOI":"10.1136\/bmj.m606","volume":"368","author":"XW Xu","year":"2020","unstructured":"Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.","journal-title":"BMJ"},{"issue":"4","key":"3022_CR60","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jinf.2020.02.016","volume":"80","author":"W Yang","year":"2020","unstructured":"Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):a multi-center study in Wenzhou city, Zhejiang. China J Infect. 2020;80(4):388\u201393.","journal-title":"China J Infect"},{"key":"3022_CR61","doi-asserted-by":"crossref","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481.","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"3022_CR62","doi-asserted-by":"crossref","unstructured":"Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020.","DOI":"10.1111\/jth.14848"},{"key":"3022_CR63","doi-asserted-by":"crossref","unstructured":"Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6):767-772.","DOI":"10.1016\/j.cmi.2020.04.012"},{"key":"3022_CR64","doi-asserted-by":"crossref","unstructured":"Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020.","DOI":"10.1111\/jth.14859"},{"issue":"10229","key":"3022_CR65","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet."},{"issue":"15","key":"3022_CR66","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323(15):1478\u20131487.","journal-title":"JAMA"},{"issue":"5","key":"3022_CR67","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S2213-2600(20)30165-X","volume":"8","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Taccone FS. Understanding pathways to death in patients with COVID-19. Lancet Respir Med. 2020;8(5):430\u2013432.","journal-title":"Lancet Respir Med"},{"key":"3022_CR68","doi-asserted-by":"crossref","unstructured":"Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6:11.","DOI":"10.1038\/s41421-020-0147-1"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-020-03022-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:50:56Z","timestamp":1625183456000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03022-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3022"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03022-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NP, EV, MC, MT, EP, AA, SS, and AR have no competing interests. MDN reports personal fees from Bayer, Daiichi Sankyo, Sanofi, Pfizer, Leo Pharma, and Aspen outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"389"}}